Your browser doesn't support javascript.
loading
Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors.
Qiu, Chenli; Wang, Jing; Zhu, Lingyan; Cheng, Xiaobo; Xia, Bili; Jin, Yanling; Qin, Ran; Zhang, LinXia; Hu, Huiliang; Yan, Jia; Zhao, Chen; Zhang, Xiaoyan; Xu, Jianqing.
Afiliación
  • Qiu C; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Wang J; Zhongshan Hospital & Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Zhu L; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Cheng X; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Xia B; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Jin Y; Clinical Research Center, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China.
  • Qin R; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Zhang L; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Hu H; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Yan J; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Zhao C; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Zhang X; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Xu J; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Front Bioeng Biotechnol ; 10: 1027619, 2022.
Article en En | MEDLINE | ID: mdl-36394017
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2022 Tipo del documento: Article País de afiliación: China